Tag Archives: Boehringer Ingelheim

Sex, Lies and Pharmaceuticals—How Female Sexual Dysfunction (a “mental disorder”) was invented by the drug industry

Female sexual dysfunction – which is claimed to affect up to two thirds of women – is a disorder invented by the pharmaceutical industry to build global markets for drugs to treat it, it is claimed today. Drug companies have invested millions in the search for a female equivalent of Viagra, so far without success. But while doing so they have stoked demand by creating a buzz around the disorder they have created, according to Ray Moynihan, a lecturer at the University of Newcastle in Australia.

Psycho/Pharma invents ‘hypoactive sexual desire disorder’ to sell female ‘Viagra’ (antidepressant)

The disorder is a branch of “female sexual dysfunction,” a widely debated term that involves everything from an inability to reach orgasm to a lack of desire. Described as a “Viagra-like drug for women” by one of the drug trials’ principal investigators, the former antidepressant flibanserin is prompting an outcry from critics who say female sexual dysfunction is a disorder the pharmaceutical industry has conjured as an attempt to capitalize on women’s complex sexuality.

Failed antidepressant being repackaged and marketed as Viagra for women…(no joke)

Flibanserin failed its trials as an anti-depressant, but when its maker, Boehringer, asked test subjects to return the unused portion, patients were reluctant. Boehringer funded a study at the University of North Carolina, which now reports that Flibanserin increases a woman’s sex drive. A lot of the media is touting this as “female Viagra,” but it’s really no such thing.